PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 1969657-9 1990 The number and size of its glycosaminoglycan chains vary with changes in cell shape and organization yielding tissue type-specific polymorphic forms of syndecan. Glycosaminoglycans 27-44 syndecan 1 Homo sapiens 152-160 1698781-6 1990 Syndecans are known to change their glycosaminoglycan composition yielding tissue-type specific polymorphic forms of syndecan (Sanderson, R., and Bernfield, M. (1988) Proc. Glycosaminoglycans 36-53 syndecan 1 Homo sapiens 117-125 2324102-4 1990 108, 1547-1556), the core protein of human syndecan can be divided into three domains: a matrix-interacting ectodomain containing putative glycosaminoglycan attachment sites, a 25-residue hydrophobic membrane-spanning domain, and a 34-residue cytoplasmic domain. Glycosaminoglycans 139-156 syndecan 1 Homo sapiens 43-51 25945286-11 2015 The role played by chondroitin sulfate glycosaminoglycan (GAG) chains on the ability of sdc1 to associate with its ligands needs further investigation. Glycosaminoglycans 58-61 syndecan 1 Homo sapiens 88-92 25945286-12 2015 At wound sites heparanase can cleave the HS GAG chains of sdc1, alter its ability to bind cytokines, and induce shedding of the ectodomain. Glycosaminoglycans 44-47 syndecan 1 Homo sapiens 58-62 23939434-2 2013 Reduced glycosaminoglycan, in endothelial HSPGs syndecan and perlecan, is associated with diabetic cardiovascular complications but changes in core protein remain controversial. Glycosaminoglycans 8-25 syndecan 1 Homo sapiens 48-56 22351752-9 2012 In addition, we found that although syndecan-1 interacts exclusively through its glycosaminoglycan chains, syndecan-4 binding relies on both its core protein and its heparan sulfate chains. Glycosaminoglycans 81-98 syndecan 1 Homo sapiens 36-46 10027728-1 1999 Syndecan-1 (CD138) is a surface proteoglycan consisting of long unbranched glycosaminoglycan (GAG) chains covalently attached to a protein backbone. Glycosaminoglycans 75-92 syndecan 1 Homo sapiens 0-10 21957484-7 2011 Using a mutant CHO-K1 cell line that lacks all glycosaminoglycans (GAGs) on its surface (CHO-745) we demonstrate that the core protein of syndecan-1 possesses the ability to modulate membrane fusion and viral spread. Glycosaminoglycans 47-65 syndecan 1 Homo sapiens 138-148 15383330-3 2004 Deletions within the syndecan-1 ectodomain (S1ED) implicate an active site within the core protein between the glycosaminoglycan attachment region and the transmembrane domain. Glycosaminoglycans 111-128 syndecan 1 Homo sapiens 21-31 15355933-10 2005 Finally, RANTES forms GAG-dependent complexes with the shed ectodomains of SD-1 and SD-4 as well as with those of CD44. Glycosaminoglycans 22-25 syndecan 1 Homo sapiens 75-79 10595940-7 1999 Our results suggest that glycosaminoglycan side chains of the HSPGs agrin, syndecan, and glypican, but not perlecan, may play an important role in the formation of both senile plaques and neurofibrillary tangles. Glycosaminoglycans 25-42 syndecan 1 Homo sapiens 75-83 10027728-1 1999 Syndecan-1 (CD138) is a surface proteoglycan consisting of long unbranched glycosaminoglycan (GAG) chains covalently attached to a protein backbone. Glycosaminoglycans 75-92 syndecan 1 Homo sapiens 12-17 10027728-1 1999 Syndecan-1 (CD138) is a surface proteoglycan consisting of long unbranched glycosaminoglycan (GAG) chains covalently attached to a protein backbone. Glycosaminoglycans 94-97 syndecan 1 Homo sapiens 0-10 10027728-1 1999 Syndecan-1 (CD138) is a surface proteoglycan consisting of long unbranched glycosaminoglycan (GAG) chains covalently attached to a protein backbone. Glycosaminoglycans 94-97 syndecan 1 Homo sapiens 12-17 8662979-10 1996 Analysis of a form of syndecan-1 that lacked glycosaminoglycan acceptor sites revealed that covalently attached glycosaminoglycans were not required for cell surface expression, microfilament association, or detergent insolubility. Glycosaminoglycans 112-130 syndecan 1 Homo sapiens 22-32 9160685-8 1997 Finally, we have demonstrated by RT-PCR, flow cytometry, and Western blotting that cultured RS cells, of B and undetermined phenotype, express syndecan-1 mRNA and produce a form of syndecan-1, recognized by the B-B4 MoAb, which is predominantly associated with glycosaminoglycans and is present at the cell surface. Glycosaminoglycans 261-279 syndecan 1 Homo sapiens 181-191 7890615-6 1995 Using rotation-mediated aggregation assays, we find that aggregation of syndecan-1-transfected cells is dependent on divalent cations and is inhibited by the following: (i) addition of heparin and heparin-like glycosaminoglycans, (ii) removal of heparan sulfate from the cell surface, or (iii) addition of exogenous purified syndecan-1. Glycosaminoglycans 210-228 syndecan 1 Homo sapiens 72-82